abstractBackgroundVascular access failure, a major cause of morbidity in hemodialysis (HD) patients, occurs mainly at stenotic endothelium following an acute thrombotic event. Microparticles (MPs) are fragments derived from injured cell membrane and are closely associated with coagulation and vascular inflammatory responses.MethodsWe investigated the relationship between levels of circulating MPs and vascular access patency in HD patients. A total of 82 HD patients and 28 healthy patients were enrolled. We used flow cytometry to measure endothelial MPs (EMPs) identified by CD31+CD42− or CD51+ and platelet-derived MPs (PMPs) identified by CD31+CD42+ in plasma samples of participants. Vascular access patency was defined as an interval from th...
Hemodialysis patients have dysfunctional immune systems, chronic inflammation and comorbidity-associ...
AbstractBackground and aimRaynaud's phenomenon (RP) is a microvascular disorder characterized by epi...
Background Anti-heparin/platelet factor 4 (PF4) antibodies may trigger severe thrombotic complicatio...
abstractBackgroundVascular access failure, a major cause of morbidity in hemodialysis (HD) patients,...
Background. Microparticles (MPs) are small cell membrane-derived vesicles regarded as both biomarker...
An increase in circulating monocyte and platelet derived microparticles during haemodialysi
Abstract Background Patients with chronic kidney disease (CKD) have a high risk of recurring thrombo...
Cardiovascular (CV) death remains the largest cause of mortality in dialysis patients, unexplained b...
Cardiovascular (CV) death remains the largest cause of mortality in dialysis patients, unexplained b...
Background. In patients with chronic renal failure (CRF), cardiovascular disease is the leading caus...
© 2017 S. Karger AG, Basel. Background: Chronic kidney disease (CKD) is associated with a unique mil...
Release of microparticles (MPs) from blood cells may occur upon various activation signals. MPs from...
Release of microparticles (MPs) from blood cells may occur upon various activation signals. MPs from...
International audienceBackground: Chronic renal failure patients are at high risk of cardiovascular ...
Objective: Microparticles (MPs) are membrane-bound vesicles derived from vascular and intravascular ...
Hemodialysis patients have dysfunctional immune systems, chronic inflammation and comorbidity-associ...
AbstractBackground and aimRaynaud's phenomenon (RP) is a microvascular disorder characterized by epi...
Background Anti-heparin/platelet factor 4 (PF4) antibodies may trigger severe thrombotic complicatio...
abstractBackgroundVascular access failure, a major cause of morbidity in hemodialysis (HD) patients,...
Background. Microparticles (MPs) are small cell membrane-derived vesicles regarded as both biomarker...
An increase in circulating monocyte and platelet derived microparticles during haemodialysi
Abstract Background Patients with chronic kidney disease (CKD) have a high risk of recurring thrombo...
Cardiovascular (CV) death remains the largest cause of mortality in dialysis patients, unexplained b...
Cardiovascular (CV) death remains the largest cause of mortality in dialysis patients, unexplained b...
Background. In patients with chronic renal failure (CRF), cardiovascular disease is the leading caus...
© 2017 S. Karger AG, Basel. Background: Chronic kidney disease (CKD) is associated with a unique mil...
Release of microparticles (MPs) from blood cells may occur upon various activation signals. MPs from...
Release of microparticles (MPs) from blood cells may occur upon various activation signals. MPs from...
International audienceBackground: Chronic renal failure patients are at high risk of cardiovascular ...
Objective: Microparticles (MPs) are membrane-bound vesicles derived from vascular and intravascular ...
Hemodialysis patients have dysfunctional immune systems, chronic inflammation and comorbidity-associ...
AbstractBackground and aimRaynaud's phenomenon (RP) is a microvascular disorder characterized by epi...
Background Anti-heparin/platelet factor 4 (PF4) antibodies may trigger severe thrombotic complicatio...